Impact of co-infections and BCG immunisation on immune responses Among household contacts of tuberculosis patients in a ugandan cohort

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Biraro, Irene A ^a   Egesa, Moses ^a   Toulza, Frederic ^c   Levin, Jonathan ^b   Cose, Stephen ^b,c   Joloba, Moses ^a   Smith, Steven ^c   Dockrell, Hazel M ^c   Katamba, Achilles ^a   Elliott, Alison M ^b,c  

^a MAKERERE UNIVERSITY   (Uganda)

^b UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 22; INTERLEUKIN 5; TUMOR NECROSIS FACTOR ALPHA; BCG VACCINE; CYTOKINE;

ADULT; ARTICLE; BCG VACCINATION; BIOASSAY; COHORT ANALYSIS; CYTOKINE RESPONSE; DISEASE PREDISPOSITION; FEMALE; HELMINTH; HOOKWORM; HOUSEHOLD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LATENT TUBERCULOSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALARIA; MALE; MIXED INFECTION; OBSERVATIONAL STUDY; PREVALENCE; RISK FACTOR; TUBERCULOSIS; UGANDA; ADOLESCENT; CHILD; EPIDEMIOLOGY; FOLLOW UP; HELMINTHIASIS; HIV INFECTIONS; IMMUNIZATION; IMMUNOLOGY; INCIDENCE; PRESCHOOL CHILD; TRANSMISSION; YOUNG ADULT;

ADOLESCENT; ADULT; BCG VACCINE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COINFECTION; CYTOKINES; EPIDEMIOLOGIC FACTORS; FEMALE; FOLLOW-UP STUDIES; HELMINTHIASIS; HIV INFECTIONS; HUMANS; IMMUNIZATION; INCIDENCE; LATENT TUBERCULOSIS; MALARIA; MALE; PREVALENCE; RISK FACTORS; TUBERCULOSIS; UGANDA; YOUNG ADULT;

EID: 84910610345     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111517     Document Type: Article

References (76)

1. WHO (2012) Global Tuberculosis Report.
2. U.S. Department of Health and Human Services, United States Centers for Disease Control and Prevention (2013) Latent Tuberculosis Infection: A Guide for Primary Health Care Providers.
3. Ministry of Health (May 2011) Uganda Malaria Programme Performance Review.
4. UNAIDS (2013) Global Report on the Global AIDS Epidemic.
5. Kabatereine NB, Tukahebwa EM, Kazibwe F, Twa-Twa JM, Barenzi J.F., et al. (2005) Soil-transmitted helminthiasis in Uganda: epidemiology and cost of control. Trop Med Int Health 10: 1187-1189.
6. Bentwich Z, Kalinkovich A, Weisman Z., Borkow G, Beyers N, et al (1999) Can eradication of helminth infections change the face of AIDS and tuberculosis? Immunology Today 11:485-487.
7. Borkow G, Bentwich Z. (2000) Eradication of helminthic infections may be essential for successful vaccination against HIV and tuberculosis. Bull World Health Organ 78: 1368-1369.
8. Nunn PP, Elliott AM, McAdam K.P. (1994) Tropical respiratory medicine. 2. Impact of human immunodeficiency virus on tuberculosis in developing countries. Thorax 49: 511-518.
9. Corbett EL, Watt CJ, Walker N, Maher D., Williams BG, et al. (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 163: 1009-1021.
10. Gray JM, Cohn D.L. (2013) Tuberculosis and HIV Coinfection. Seminars in Respiratory and Critical Care Medicine 34.
11. Walzl G, Ronacher K, Hanekom W., Scriba TJ, Zumla A. (2011) Immunological biomarkers of tuberculosis. Nat Rev Immunol 11: 343-354.
12. Elias D, Wolday D, Akuffo H., Petros B, Bronner U, et al (2001) Effect of deworming on human T cell responses to mycobacterial antigens in helminthexposed individuals before and after bacille Calmette-Guerin (BCG) vaccination. Clin Exp Immunol 123: 219-225.
13. Elias D, Akuffo H, Thors C., Pawlowski A, Britton S. (2005) Low dose chronic Schistosoma mansoni infection increases susceptibility to Mycobacterium bovis BCG infection in mice. Clin Exp Immunol 139: 398-404.
14. Kamal SM, El Sayed Khalifa K (2006) Immune modulation by helminthic infections: worms and viral infections. Parasite Immunol 28: 483-496.
15. Parakkal JG, Anuradha R, Kumaran P.P., Chandrasekaran V., Nutman TB, et al. (2013) Modulation of mycobacterial-specific Th1 and th17 cells in latent tuberculosis by coincident hookworm infection. J Immunol 190: 5161-5168.
16. Salgame P, Yap GS, Gause W.C. (2013) Effect of helminth-induced immunity on infections with microbial pathogens. Nat Immunol 14: 1118-1126.
17. Rafi W, Ribeiro-Rodrigues R, Ellner J.J., Salgame P. (2012) 'Coinfection-helminthes and tuberculosis'. Curr Opin HIV AIDS 7: 239-244.
18. Artavanis-Tsakonas K., Tongren JE, Riley E.M. (2003) The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology. Clin Exp Immunol 133: 145-152.
19. Engwerda CR, Good M.F. (2005) Interactions between malaria parasites and the host immune system. Curr Opin Immunol 17: 381-387.
20. McCall MB, Sauerwein R.W. (2010) Interferon-gamma - central mediator of protective immune responses against the pre-erythrocytic and blood stage of malaria. J Leukoc Biol 88: 1131-1143.
21. Riley EM, Andersson G, Otoo L.N., Jepsen S., Greenwood B.M. (1988) Cellular immune responses to Plasmodium falciparum antigens in Gambian children during and after an acute attack of falciparum malaria. Clin Exp Immunol 73: 17-22.
22. Riley EM, Schneider G, Sambou I., Greenwood B.M. (1989) Suppression of cellmediated immune responses to malaria antigens in pregnant Gambian women. Am J Trop Med Hyg 40: 141-144.
23. Millington OR, Di Lorenzo C, Phillips RS, Garside P, Brewer J.M. (2006) Suppression of adaptive immunity to heterologous antigens during Plasmodium infection through hemozoin-induced failure of dendritic cell function. J Biol 5: 5.
24. Chene A, Nylen S, Donati D., Bejarano MT, Kironde F, et al. (2011) Effect of acute Plasmodium falciparum malaria on reactivation and shedding of the eight human herpes viruses. PLoS One 6: e26266.
25. Pass RF (1985) Epidemiology and transmission of cytomegalovirus. J Infect Dis 152: 243-248.
26. Grinde B (2013) Herpesviruses: latency and reactivation - viral strategies and host response. J Oral Microbiol 5.
27. van der Sande MA, Kaye S, Miles D.J., Waight P., Jeffries DJ, et al. (2007) Risk factors for and clinical outcome of congenital cytomegalovirus infection in a peri-urban West-African birth cohort. PLoS One 2: e492.
28. Fletcher JM, Vukmanovic-Stejic M, Dunne P.J., Birch KE, Cook JE, et al. (2005) Cytomegalovirus-specific CD4+ T cells in healthy carriers are continuously driven to replicative exhaustion. J Immunol 175: 8218-8225.
29. Essa S, Pacsa A, Raghupathy R., Said T, Nampoory MR, et al (2009) Low levels of Th1-type cytokines and increased levels of Th2-type cytokines in kidney transplant recipients with active cytomegalovirus infection. Transplant Proc 41: 1643-1647.
30. Walton SM, Wyrsch P, Munks M.W., Zimmermann A., Hengel H, et al. (2008) The dynamics of mouse cytomegalovirus-specific CD4 T cell responses during acute and latent infection. J Immunol 181: 1128-1134.
31. Ministry of Health (2010) Manual of the National Tuberculosis and Leprosy Programme. 2nd Edition.
32. Cellestis (March 2011) The Whole Blood IFN-gamma Test Measuring Responses to ESAT-6, CFP-10 & TB 7.7 (p. 4) Peptide Antigens. Quantiferon-TB Gold, Package Insert, Cellestis.
33. Melrose WD, Turner PF, Pisters P, Turner B. (2000) An improved Knott's concentration test for the detection of microfilariae. Trans Roy Soc Trop Med Hyg Mar-Apr; 94: 176.
34. Katz N, Chaves A, Pellegrino J. (1972) A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 14: 397-400.
35. Fleiss JL, Levin B, Paik M.C. (2003) Statistical Methods for Rates and Proportions: New York: Wiley.
36. Victora CG, Huttly SR, Fuchs S.C., Olinto M.T. (1997) The role of conceptual frameworks in epidemiological analysis: a hierarchical approach. Int J Epidemiol 26: 224-227.
37. Flom PL, Cassell D.L. (2007) Stopping stepwise: Why stepwise and similar selection methods are bad, and what you should use. NorthEast SAS Users Group (NESUG): Statistics and Data Analysis.
38. Royston PA, G; Sauerbrei, W (1999) The use of fractional polynomials to model continous risk variables in epidemiology. International Journal of Epidemiology 28: 964-974.
39. McGuinness D, Bennett S, Riley E. (1997) Statistical analysis of highly skewed immune response data. J Immunol Methods 201: 99-114.
40. Lienhardt C, Sillah J, Fielding K., Donkor S, Manneh K, et al (2003) Risk factors for tuberculosis infection in children in contact with infectious tuberculosis cases in the Gambia, West Africa. Pediatrics 111: e608-614.
41. Narasimhan P, Wood J, Macintyre C.R., Mathai D. (2013) Risk factors for tuberculosis. Pulm Med 2013: 828939.
42. Shaler CR, Horvath CN, McCormick S, Jeyanathan M., Khera A, et al. (2013) Continuous and discontinuous cigarette smoke exposure differentially affects protective Th1 immunity against pulmonary tuberculosis. PLoS One 8: e59185.
43. Leung CC, Lam TH, Ho K.S., Yew WW, Tam CM, et al. (2010) Passive smoking and tuberculosis. Arch Intern Med 170: 287-292.
44. Stampfli MR, Anderson G.P. (2009) How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nat Rev Immunol 9: 377-384.
45. Elliott AM, Hayes RJ, Halwiindi B, Luo N., Tembo G, et al. (1993) The impact of HIV on infectiousness of pulmonary tuberculosis: a community study in Zambia. AIDS Jul; 7: 981-987.
46. Espinal MA, Peréz EN, Baéz J, Hénriquez L, Fernández K, et al. (2000) Infectiousness of Mycobacterium tuberculosis in HIV-1 infected patients with tuberculosis: a prospective study. The Lancet Jan 22; 355: 275-280.
47. Cauthen GM, Dooley SW, Onorato I.M., Ihle WW, Burr JM, et al. (1996) Transmission of Mycobacterium tuberculosis from tuberculosis patients with HIV infection or AIDS. Am J Epidemiol 144: 69-77.
48. Sutherland JS, Adetifa IM, Hill P.C., Adegbola RA, Ota M.O. (2009) Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease. Eur J Immunol 39: 723-729.
49. Nemeth J, Winkler HM, Karlhofer F, Selenko-Gebauer N, Graninger W., et al. (2010) T cells co-producing Mycobacterium tuberculosis-specific type 1 cytokines for the diagnosis of latent tuberculosis. Eur Cytokine Netw 21: 34-39.
50. Mahan CS, Zalwango S, Thiel B.A., Malone LL, Chervenak KA, et al. (2012) Innate and adaptive immune responses during acute M. tuberculosis infection in adult household contacts in Kampala, Uganda. Am J Trop Med Hyg 86: 690-697.
51. Silveira H, Ordway D, Dockrell H., Jackson M, Ventura F. (1997) Cell-mediated immune responses to mycobacterial antigens in patients with pulmonary tuberculosis and HIV infection. Clin Exp Immunol 110: 26-34.
52. Elliott AM, Hurst TJ, Balyeku M.N., Quigley MA, Kaleebu P, et al. (1999) The immune response to Mycobacterium tuberculosis in HIV-infected and uninfected adults in Uganda: application of a whole blood cytokine assay in an epidemiologicalstudy. Int J Tuberc Lung Dis Mar 3: 239-247.
53. Lodi S, del Amo J, d'Arminio Monforte A, Abgrall S, Sabin C, et al. (2013) Risk of tuberculosis following HIV seroconversion in high-income countries. Thorax 68: 207-213.
54. Wood R, Middelkoop K, Myer L., Grant AD, Whitelaw A, et al. (2007) Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control. Am J Respir Crit Care Med 175: 87-93.
55. Karo B, Haas W, Kollan C., Gunsenheimer-Bartmeyer B, Hamouda O, et al (2014) Tuberculosis among people living with HIV/AIDS in the German Clin Surv HIV Cohort: long-term incidence and risk factors. BMC Infect Dis 14: 148.
56. Elliott AM, Luo N, Tembo G., Halwiindi B, Steenbergen G, et al (1990) Impact of HIV on tuberculosis in Zambia: a cross sectional study. BMJ 301: 412-415.
57. Oni T, Gideon HP, Bangani N, Tsekela R., Seldon R, et al. (2012) Smoking, BCG and employment and the risk of tuberculosis infection in HIV-infected persons in South Africa. PLoS One 7: e47072.
58. Eisenhut M, Paranjothy S, Abubakar I., Bracebridge S, Lilley M, et al (2009) BCG vaccination reduces risk of infection with Mycobacterium tuberculosis as detected by gamma interferon release assay. Vaccine 27: 6116-6120.
59. Basu Roy R., Sotgiu G, Altet-Gomez N, Tsolia M., Ruga E, et al. (2012) Identifying predictors of interferon-gamma release assay results in pediatric latent tuberculosis: a protective role of bacillus Calmette-Guerin?: a pTB-NET collaborative study. Am J Respir Crit Care Med 186: 378-384.
60. Soysal A, Millington KA, Bakir M, Dosanjh D., Aslan Y, et al. (2005) Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet 366: 1443-1451.
61. Eriksen J, Chow JY, Mellis V, Whipp B., Walters S, et al. (2010) Protective effect of BCG vaccination in a nursery outbreak in 2009: time to reconsider the vaccination threshold? Thorax 65: 1067-1071.
62. Colditz GA, Brewer TF, Berkey C.S., Wilson ME, Burdick E, et al. (1994) Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 271: 698-702.
63. Lalvani A, Sridhar S. (2010) BCG vaccination: 90 years on and still so much to learn. Thorax 65: 1036-1038.
64. Whalen CC, Chiunda A, Zalwango S., Nshuti L, Jones-Lopez E, et al. (2006) Immune correlates of acute Mycobacterium tuberculosis infection in household contacts in Kampala, Uganda. Am J Trop Med Hyg 75: 55-61.
65. Madura Larsen J., Benn CS, Fillie Y, van der Kleij D, Aaby P, et al. (2007) BCG stimulated dendritic cells induce an interleukin-10 producing T-cell population with no T helper 1 or T helper 2 bias in vitro. Immunology 121: 276-282.
66. Glinz D, Silue KD, Knopp S, Lohourignon L.K., Yao KP, et al. (2010) Comparing diagnostic accuracy of Kato-Katz, Koga agar plate, ether-concentration, and FLOTAC for Schistosoma mansoni and soil-transmitted helminths. PLoS Negl Trop Dis 4: e754.
67. WHO (2002) Prevention and Control of Schistosomiasis and Soil-Transmitted Helminthiasis: Report of a WHO Expert Committee.
68. WHO (1994, 5-7 December) Report of the WHO informal consultation on hookworm infection and anaemia in girls and women. WHO/CTD/SIP/96.1.
69. Woodburn PW, Muhangi L, Hillier S., Ndibazza J, Namujju PB, et al (2009) Risk factors for helminth, malaria, and HIV infection in pregnancy in Entebbe, Uganda. PLoS Negl Trop Dis 3: e473.
70. Markowitz N, Hansen NI, Wilcosky T.C., Hopewell PC, Glassroth J, et al. (1993) Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Pulmonary Complications of HIV Infection Study Group. Ann Intern Med 119: 185-193.
71. Cobelens FG, Egwaga SM, van Ginkel T, Muwinge H, Matee M.I., et al. (2006) Tuberculin skin testing in patients with HIV infection: limited benefit of reduced cutoff values. Clin Infect Dis 43: 634-639.
72. Oni T, Gideon HP, Bangani N, Tsekela R., Seldon R, et al. (2012) Risk factors associated with indeterminate gamma interferon responses in the assessment of latent tuberculosis infection in a high-incidence environment. Clin Vaccine Immunol 19: 1243-1247.
73. Seshadri C, Uiso LO, Ostermann J, Diefenthal H., Shao HJ, et al. (2008) Low sensitivity of T-cell based detection of tuberculosis among HIV co-infected Tanzanian in-patients. East Afr Med J 85: 442-449.
74. Cattamanchi A, Smith R, Steingart K.R., Metcalfe JZ, Date A, et al. (2011) Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. J Acquir Immune Defic Syndr 56: 230-238.
75. Rangaka MX, Wilkinson KA, Seldon R, Van Cutsem G, Meintjes GA, et al (2007) Effect of HIV-1 infection on T-Cell-based and skin test detection of tuberculosis infection. Am J Respir Crit Care Med 175: 514-520.
76. Ramos JM, Robledano C, Masia M., Belda S, Padilla S, et al (2012) Contribution of interferon gamma release assays testing to the diagnosis of latent tuberculosis infection in HIV-infected patients: a comparison of QuantiFERON-TB Gold In Tube, T-SPOT. TB and tuberculin skin test. BMC Infect Dis 12: 169.